Biotech firms offer extraordinary growth potential thanks to their development of new drugs.
If a drug wins FDA approval, the company's...
The numbers are staggering. Over the next six years, the biotech market is expected to add an additional $593 billion in value - a 419% increase...
By 2025, the biotech industry will be worth will be $727 billion - a 120% increase over its total value in 2015.
To help you take...
Since hitting a high in late January, the iShares Nasdaq Biotechnology ETF has slumped more than 11%. But that doesn't mean investors should stop...
Biotech stocks have already netted investors huge gains.
In fact, we expect prices to skyrocket even further as the industry becomes a...
Biotech stocks have been getting hit hard in early 2018, but it's largely because of market overreactions to minor setbacks and...
Biotech stocks were among 2017's best performers, until news broke in October that congressional Republicans ditched efforts to repeal and replace...
Some of the most outrageous drug price increases of 2016 have placed huge burdens on patients and caregivers alike. According to an Oct. 11 report...
